arrow
返回

Vericiguat: First Approval

delete2021-03-26
delete41
PRE
AI
A
Anthony Markham *
S
Sean T. Duggan
DOI:10.1007/s40265-021-01496-zdelete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Vericiguat (VERQUVO (TM); Merck & Co, Bayer AG) is a soluble guanylate cyclase (sGC) stimulator being developed for the treatment of chronic heart failure. Vericiguat stimulates sGC and cGMP production independent of nitric oxide (NO) and enhances the effects of NO by stabilizing the NO-sGC binding. Based on the results of the phase III VICTORIA trial vericiguat was recently approved in the USA for risk reduction in patients with heart failure and ejection fraction < 45%. This article summarizes the milestones in the development of vericiguat leading to this first approval.
Keyword:
GUANYLATE-CYCLASE STIMULATOR
CHRONIC HEART-FAILURE
NATRIURETIC PEPTIDE
EJECTION FRACTION
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Drugs 封面图
Drugs
IF:
14.4
论文数:
8.4K
被引数:
2.3W

机构

暂无机构信息
引用论文

引用论文

A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic
err2022-08-06
err0
errOAAI
errIshnoor Kaur; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vetriselvan Subramanian; Shivkanya Fuloria; Neeraj Kumar Fuloria; Mahendran Sekar; Hamed Ghaleb Dailah; Amal M. Alsubayiel; Saurabh Bhatia; Ahmed Al-Harrasi; Lotfi Aleya; Simona Bungau
err分享
err收藏
err分享
err收藏
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction心力衰竭和射血分数降低患者的Vericiguat
err2020-05-14
err833
errOAAI
errArmstrong, Paul W.; Pieske, Burkert; Anstrom, Kevin J.; Ezekowitz, Justin; Hernandez, Adrian F.; Butler, Javed; Lam, Carolyn S. P.; Ponikowski, Piotr; Voors, Adriaan A.; Jia, Gang; McNulty, Steven E.; Patel, Mahesh J.; Roessig, Lothar; Koglin, Joerg; O'Connor, Christopher M.
err分享
err收藏
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
err2017-03-22
err289
errOAAI
errPieske, Burkert; Maggioni, Aldo P.; Lam, Carolyn S. P.; Pieske-Kraigher, Elisabeth; Filippatos, Gerasimos; Butler, Javed; Ponikowski, Piotr; Shah, Sanjiv J.; Solomon, Scott D.; Scalise, Andrea-Viviana; Mueller, Katharina; Roessig, Lothar; Gheorghiade, Mihai
err分享
err收藏
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
err2020-11-01
err113
errOAAI
errEzekowitz, Justin A.; O'Connor, Christopher M.; Troughton, Richard W.; Alemayehu, Wendimagegn G.; Westerhout, Cynthia M.; Voors, Adriaan A.; Butler, Javed; Lam, Carolyn S. P.; Ponikowski, Piotr; Emdin, Michele; Patel, Mahesh J.; Pieske, Burkert; Roessig, Lothar; Hernandez, Adrian F.; Armstrong, Paul W.
err分享
err收藏
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
err2017-06-12
err149
errOAAI
errFollmann, Markus; Ackerstaff, Jens; Redlich, Gorden; Wunder, Frank; Lang, Dieter; Kern, Armin; Fey, Peter; Griebenow, Nils; Kroh, Walter; Becker-Pelster, Eva-Maria; Kretschmer, Axel; Geiss, Volker; Li, Volkhart; Straub, Alexander; Mittendorf, Joachim; Jautelat, Rolf; Schirok, Hartmut; Schlemmer, Karl-Heinz; Lustig, Klemens; Gerisch, Michael; Knorr, Andreas; Tine, Hanna; Mondritzki, Thomas; Truebel, Hubert; Sandner, Peter; Stasch, Johannes-Peter
err分享
err收藏
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction The SOCRATES-REDUCED Randomized Trial
err2015-12-01
err306
errOAAI
errGheorghiade, Mihai; Greene, Stephen J.; Butler, Javed; Filippatos, Gerasimos; Lam, Carolyn S. P.; Maggioni, Aldo P.; Ponikowski, Piotr; Shah, Sanjiv J.; Solomon, Scott D.; Kraigher-Krainer, Elisabeth; Samano, Eliana T.; Mueller, Katharina; Roessig, Lothar; Pieske, Burkert
err分享
err收藏
没有更多内容